Preoperative data, including routine blood tests and tumor markers (e.g., alpha-fetoprotein [AFP], carbohydrate antigen 19-9 [CA19-9], carcinoembryonic antigen [CEA]), were collected. This evidence concerns the gene CEACAM5 and neoplasm.